Cosunter(300436.SZ)

Last Updated 00:00:00
longbridge loading

Innovative drug concept stocks rapidly plummeted, with NEPTUNUS hitting the daily limit, RemeGen falling more than 10%, and many stocks including Cosunter, Rundu Pharma, Sunshine Guojian Pharmaceutical, SL PHARM, and HITECK dropping more than 6%

Wallstreetcn·
SH
512290
+0.21%
SZ
002038
+0.48%
SZ
002923
+0.65%
Wallstreetcn·
SH
512290
+0.21%
SZ
002038
+0.48%
SZ
002923
+0.65%

The three major A-share indices all closed higher

36Kr·
SZ
300436
+3.11%
SH
601872
+2.52%
SZ
399006
-0.16%
36Kr·
SZ
300436
+3.11%
SH
601872
+2.52%
SZ
399006
-0.16%

The three major A-share indices closed mixed, with media stocks rising

36Kr·
SZ
300436
+3.11%
SZ
300364
+1.28%
SZ
300251
+3.34%
36Kr·
SZ
300436
+3.11%
SZ
300364
+1.28%
SZ
300251
+3.34%

Cosunter: Net loss of RMB 44.8963 million in the third quarter, a decrease of 29.75%

Zhitong·
SZ
300436
+3.11%
Zhitong·
SZ
300436
+3.11%

Cosunter and ZZPZH established a pharmaceutical company with a registered capital of 50 million yuan

Zhitong·
SZ
300436
+3.11%
SH
600436
-1.46%
Zhitong·
SZ
300436
+3.11%
SH
600436
-1.46%

Cosunter and ZZPZH established a pharmaceutical company with a registered capital of 50 million

Zhitong·
SZ
300436
+3.11%
SH
600436
-1.46%
Zhitong·
SZ
300436
+3.11%
SH
600436
-1.46%

The three major A-share indices collectively rose at the midday break, with the innovative drug concept experiencing a surge

36Kr·
SZ
002244
+5.17%
SZ
300436
+3.11%
SZ
002940
+3.79%
36Kr·
SZ
002244
+5.17%
SZ
300436
+3.11%
SZ
002940
+3.79%

Cosunter: Research results of the innovative drug GST-HG131 for hepatitis B treatment accepted as the latest breakthrough abstract report at the annual meeting of the American Association for the Study of Liver Diseases

Zhitong·
SZ
300436
+3.11%
Zhitong·
SZ
300436
+3.11%

Innovative drug concept experiences a surge, CCHT rises over 8%

Zhitong·
SH
688331
+0.44%
HK
09995
-1.05%
SZ
300436
+3.11%
Zhitong·
SH
688331
+0.44%
HK
09995
-1.05%
SZ
300436
+3.11%

The innovative drug sector adjusted at the beginning of the trading session, with Aosaikang hitting the limit down, followed by declines in Cosunter, Jimin Health, Huili Pharmaceutical-W, Saili Medical, Rongchang Bio, Wanbangde, and others

Zhitong·
SZ
300436
+3.11%
SZ
300361
0.00%
Zhitong·
SZ
300436
+3.11%
SZ
300361
0.00%
© 2026 Longbridge｜Disclaimer